mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

See allHide authors and affiliations

Science  25 Mar 2021:
DOI: 10.1126/science.abg9175

Article Information

Print ISSN: 
Online ISSN: 
  • Received for publication February 4, 2021
  • Accepted for publication March 19, 2021
  • .

Author Information

  1. Leonidas Stamatatos1,2,*,
  2. Julie Czartoski1,
  3. Yu-Hsin Wan1,
  4. Leah J. Homad1,
  5. Vanessa Rubin1,
  6. Hayley Glantz1,
  7. Moni Neradilek1,
  8. Emilie Seydoux1,
  9. Madeleine F. Jennewein1,
  10. Anna J. MacCamy1,
  11. Junli Feng1,
  12. Gregory Mize1,
  13. Stephen C. De Rosa1,3,
  14. Andrés Finzi4,5,6,
  15. Maria P. Lemos1,
  16. Kristen W. Cohen1,
  17. Zoe Moodie1,
  18. M. Juliana McElrath1,2,7,*,
  19. Andrew T. McGuire1,2,3,*
  1. 1Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  2. 2Department of Global Health, University of Washington, Seattle, WA, USA.
  3. 3Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  4. 4Centre de Recherche du CHUM, Montréal, QC, Canada.
  5. 5Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada.
  6. 6Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
  7. 7Department of Medicine, University of Washington, Seattle, WA, USA.
  1. *Corresponding author. Email: amcguire{at} (A.T.M.); lstamata{at} (L.S.); jmcelrat{at} (M.J.M.)


Article usage

Article usage: March 2021 to June 2021

Mar 2021683489917197
Apr 20211401502556781
May 2021598160662346
Jun 20212975955768

Stay Connected to Science

Navigate This Article